Skip to content
Axsome Therapeutics, Inc. (AXSM) Stock Price, Key Stats & Insider Trading
Home / Companies / AXSM AXS
Axsome Therapeutics, Inc. (AXSM) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d) Watch AXSM
Latest AXSM Insider Trades
About Axsome Therapeutics, Inc. (AXSM) Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
Headquarters NEW YORK, NY
Employees 925
Listed 2015
Exchange XNAS https://www.axsome.com SEC filings for AXSM on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 13 201,352 $46.83M Grant or award 4 6,884 Option exercise 18 375,432
AXSM Insider Transactions (Form 4) 65 48 Form 4 filings on record, the earliest from Nov 20, 2024, newest first. Filing history page 1 of 2.
Date Insider Transaction Security Shares Price Value Aug 5, 2026 HT Herriot Tabuteau - Officer Option exercise Common Stock
Recent AXSM Form 8-K Filings 5
Recent AXSM Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 6, 2026 Herriot Tabuteau Officer 4,660 $979K View on EDGAR Aug 5, 2026 Herriot Tabuteau Officer
AXSM Insider Trading - FAQ
What is the latest insider trade for AXSM? Axsome Therapeutics, Inc. (AXSM) had 14 insider filings in the last 90 days, with the most recent on 2026-08-07. The full record for AXSM runs to 48 Form 4 filings, the earliest from 2024-11-20. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying AXSM stock? No insider purchases of AXSM were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling AXSM stock? 13 insider sales of AXSM were filed in the last 90 days, totaling $46.83M.
Where can I see AXSM SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks AXSM Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow AXSM insider buys? Create a free InsiderAlpha account and press Watch on this page to add AXSM to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track AXSM insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free
Market cap $10.42B
P/E ratio -
Dividend yield -
Average volume 850.4K
52 week high $260.19
52 week low $112.90
Today's high $205.70
Today's low $199.00
Open $205.70
Volume 441.3K
Previous close $206.27
Shares outstanding 52.38M Market cap
$10.42B
925 employees
AXSM Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 13 sales totaling $46.83M.
Most-Active AXSM Insiders - Last 90 Days 9 Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Aug 5, 2026 HT Herriot Tabuteau - Officer Open-market sale Common Stock 45,004 $212.01 $9.54M
Aug 6, 2026 HT Herriot Tabuteau - Officer Option exercise Common Stock 4,660 $4.95 $23K
Aug 6, 2026 HT Herriot Tabuteau - Officer Open-market sale Common Stock 4,660 $213.95 $997K
Aug 5, 2026 HT Herriot Tabuteau - Officer Option exercise Stock Option (Right to Buy) 45,004 $0.00 -
Aug 6, 2026 HT Herriot Tabuteau - Officer Option exercise Stock Option (Right to Buy) 4,660 $0.00 -
Jul 1, 2026 HT Herriot Tabuteau - Officer Option exercise Stock Option (Right to Buy) 49,666 $0.00 -
Jul 1, 2026 HT Herriot Tabuteau - Officer Option exercise Common Stock 49,666 $4.95 $246K
Jul 1, 2026 HT Herriot Tabuteau - Officer Open-market sale Common Stock 49,666 $240.25 $11.93M
Jun 10, 2026 RJ Roger Jeffs Open-market sale Common Stock 286 $246.18 $70K
Jun 11, 2026 RJ Roger Jeffs Open-market sale Common Stock 286 $249.12 $71K
Jun 8, 2026 RJ Roger Jeffs Option exercise Restricted Stock Units 1,429 $0.00 -
Jun 8, 2026 RJ Roger Jeffs Option exercise Common Stock 1,429 - -
Jun 8, 2026 MS Mark E. Saad Option exercise Restricted Stock Units 1,429 $0.00 -
Jun 8, 2026 SM Susan Mahony Option exercise Restricted Stock Units 1,429 $0.00 -
Jun 9, 2026 SM Susan Mahony Open-market sale Common Stock 300 $237.21 $71K
Jun 10, 2026 SM Susan Mahony Open-market sale Common Stock 300 $246.18 $74K
Jun 10, 2026 MC Mark Coleman Open-market sale Common Stock 643 $249.00 $160K
Jun 8, 2026 MC Mark Coleman Option exercise Restricted Stock Units 1,429 $0.00 -
Jun 5, 2026 MC Mark Coleman Grant or award Restricted Stock Units 1,721 $0.00 -
Jun 5, 2026 SM Susan Mahony Grant or award Restricted Stock Units 1,721 $0.00 -
Jun 9, 2026 HT Herriot Tabuteau - Officer Option exercise Common Stock 49,670 $4.95 $246K
Jun 9, 2026 HT Herriot Tabuteau - Officer Open-market sale Common Stock 49,670 $241.01 $11.97M
Jun 9, 2026 HT Herriot Tabuteau - Officer Option exercise Stock Option (Right to Buy) 49,670 $0.00 -
Jun 9, 2026 NP Nick Pizzie - Officer Option exercise Common Stock 33,000 $3.50 $116K
Jun 9, 2026 NP Nick Pizzie - Officer Open-market sale Common Stock 33,000 $240.09 $7.92M
Jun 9, 2026 NP Nick Pizzie - Officer Option exercise Stock Option (Right to Buy) 33,000 $0.00 -
Jun 5, 2026 MS Mark E. Saad Grant or award Restricted Stock Units 1,721 $0.00 -
Jun 5, 2026 RJ Roger Jeffs Grant or award Restricted Stock Units 1,721 $0.00 -
May 29, 2026 MC Mark Coleman Open-market sale Common Stock 6,000 $233.46 $1.40M
Jun 1, 2026 MC Mark Coleman Open-market sale Common Stock 6,000 $230.30 $1.38M
Jun 2, 2026 MC Mark Coleman Open-market sale Common Stock 5,537 $223.39 $1.24M
May 4, 2026 MJ Mark L. Jacobson - Officer Option exercise Common Stock 4,517 $12.95 $58K
May 4, 2026 MJ Mark L. Jacobson - Officer Open-market sale Common Stock 4,517 $227.94 $1.03M
May 5, 2026 MJ Mark L. Jacobson - Officer Open-market sale Common Stock 233 $228.18 $53K
May 4, 2026 MJ Mark L. Jacobson - Officer Option exercise Stock Option (Right to Buy) 4,517 $0.00 -
May 5, 2026 MJ Mark L. Jacobson - Officer Option exercise Stock Option (Right to Buy) 233 $0.00 -
Apr 21, 2026 MJ Mark L. Jacobson - Officer Grant or award Performance Stock Units 8,669 $0.00 -
Apr 21, 2026 HT Herriot Tabuteau - Officer Grant or award Performance Stock Units 24,081 $0.00 -
Apr 22, 2026 AM Ari Maizel - Officer Option exercise Common Stock 7,500 $70.73 $530K
Apr 22, 2026 AM Ari Maizel - Officer Open-market sale Common Stock 7,500 $182.42 $1.37M
Apr 22, 2026 AM Ari Maizel - Officer Option exercise Stock Option (Right to Buy) 7,500 $0.00 -
Apr 21, 2026 NP Nick Pizzie - Officer Grant or award Performance Stock Units 8,188 $0.00 -
Apr 21, 2026 HM Hunter R. Murdock - Officer Grant or award Performance Stock Units 7,224 $0.00 -
Feb 26, 2026 HT Herriot Tabuteau - Officer Grant or award Restricted Stock Units 54,623 $0.00 -
Feb 26, 2026 NP Nick Pizzie - Officer Grant or award Restricted Stock Units 18,570 $0.00 -
Feb 26, 2026 HM Hunter R. Murdock - Officer Grant or award Restricted Stock Units 16,385 $0.00 -
Feb 26, 2026 AM Ari Maizel - Officer Grant or award Restricted Stock Units 16,385 $0.00 -
Feb 26, 2026 MC Mark Coleman Open-market sale Common Stock 25,000 $161.11 $4.03M
Feb 26, 2026 MJ Mark L. Jacobson - Officer Option exercise Common Stock 35,378 $2.85 $101K
Feb 26, 2026 MJ Mark L. Jacobson - Officer Open-market sale Common Stock 35,378 $161.88 $5.73M
Feb 26, 2026 MJ Mark L. Jacobson - Officer Option exercise Stock Option (Right to Buy) 35,378 $0.00 -
Feb 23, 2026 MC Mark Coleman Option exercise Common Stock 6,250 $4.95 $31K
Feb 23, 2026 MC Mark Coleman Option exercise Stock Option (Right to Buy) 6,250 $0.00 -
Feb 20, 2026 MC Mark Coleman Option exercise Common Stock 12,485 $4.95 $62K
Feb 20, 2026 MC Mark Coleman Option exercise Stock Option (Right to Buy) 12,485 $0.00 -
Feb 10, 2026 MC Mark Coleman Option exercise Common Stock 5,193 $8.02 $42K
Feb 10, 2026 MC Mark Coleman Option exercise Stock Option (Right to Buy) 5,193 $0.00 -
Feb 2, 2026 HT Herriot Tabuteau - Officer Option exercise Common Stock 32,410 $8.02 $260K
Feb 2, 2026 HT Herriot Tabuteau - Officer Open-market sale Common Stock 32,410 $185.60 $6.02M
Feb 2, 2026 HT Herriot Tabuteau - Officer Option exercise Stock Option (Right to Buy) 32,410 $0.00 -
$IONS
IONIS PHARMACEUTICALS INC